The Advisory Team at InterVenn Biosciences is composed of expert advisors who provide strategic insights and guidance on the company's innovative glycoproteomic technologies. They collaborate with leadership to refine research initiatives, enhance clinical applications, and ensure the alignment of solutions with market needs in precision medicine, particularly for various cancer types. Their expertise helps drive the development of additional applications within the Vista suite, fostering advancements in patient management and treatment outcomes.
View all